05/18/2026
Most healthcare systems still treat adherence like a simple yes-or-no issue.
Research says otherwise.
In Adherence in Liver Transplant Recipients, Burra et al. found that medication nonadherence ranged from 15%–40%, while appointment nonadherence ranged from 3%–47% in transplant patients.
Even more important:
The study emphasized that adherence is not binary.
A patient may:
💡take medication late,
💡occasionally miss doses,
💡reschedule appointments repeatedly,
💡skip bloodwork,
💡or inconsistently follow medical instructions
…without being fully recognized as behaviorally high-risk.
That distinction matters.
Because occasionally being late with medication is not behaviorally equivalent to abandoning treatment for days or weeks.
The problem is many systems still measure adherence with tools that are too broad, inconsistent, or behaviorally underpowered to detect real-time compliance drift.
The study also found that:
✨low social support,
✨avoidant coping,
✨affective dysregulation,
✨financial instability,
✨and lower conscientiousness
were associated with poorer adherence outcomes.
This reinforces a critical issue in surgical and transplant care:
✨Patients don’t suddenly become high-risk overnight.
Behavioral instability often appears gradually through:
🔗inconsistency,
🔗disengagement,
🔗partial adherence,
🔗and environmental strain.
If healthcare systems are not identifying those behavioral patterns early,
then behavioral risk is being underestimated long before medical complications appear.